About the Company
xbiotech is developing a first-in-class monoclonal antibody (mabp1) to inhibit chronic inflammation. chronic (sterile) inflammatory responses are involved in the progression of many serious and common diseases. mabp1 is being investigated in many important areas of medicine, including: cancer, leukemia (phase 1); type 2 diabetes (phase2); psoriasis (phase 2); and vascular disease (phase 2). mabp1 is a true human™ antibody cloned from a natural human immune response and—unlike currently marketed antibodies—it has not undergone any modification to alter its function. it has exhibited the best potential tolerability and safety during the clinical trials. xbiotech has established a current good manufacturing practices (cgmp) program to commercialize its lead product candidate. the company has purchased land and designed a commercial-scale plant with 25,000l total bioreactor capacity. construction of the facility is planned to commence in 4th quarter 2011..
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $XBIT News
XBiotech Inc.'s (NASDAQ:XBIT) top owners are retail investors with 44% stake, while 44% is held by insiders
XBiotech's significant retail investors ownership ... Insiders own 44% of XBiotech A look at the shareholders of XBiotech Inc. (NASDAQ:XBIT) can tell us which group is most powerful.
XBiotech Inc XBIT
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...
XBiotech Inc 4XB
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...
The Zacks Analyst Blog Highlights Quince Therapeutics and XBiotech
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks ...
XBiotech Inc (XBIT) Earnings Dates & Reports
View upcoming earnings forecasts and in-depth analysis of company forecasts.
Welcome to Inc.'s Directory of B2B Excellence
They all made it through Inc.'s proprietary vetting process, based in part on testimonials from other clients. As any entrepreneur knows, the right partnership can make all the difference.
STIHL Inc.
This company has paid to receive expanded profile features. About STIHL Inc. Virginia-based STIHL Inc. is the U.S. affiliate for the global STIHL group and the manufacturer of the number one ...
Stocks A-Z
China XSHG Banking Xiamen C&D Inc. A (600153) China XSHG Transportation Services Xiamen Changelight Co. Ltd. (300102) China XSHE Industrial Electronics Xiamen Comfort Science & Technology Group Co ...
Block Inc.
1 Day SQ -1.32% DJIA -0.49% S&P 500 -0.65% Technology -1.75% The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum ...
XBiotech Inc.'s (NASDAQ:XBIT) top owners are retail investors with 44% stake, while 44% is held by insiders
However, on some occasions too much power is concentrated within this group. Our information suggests that insiders maintain a significant holding in XBiotech Inc.. Insiders have a US$86m stake in ...
XBiotech Inc.
Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...
Loading the latest forecasts...